Comparative Analysis of Post‐Authorization Measures for Advanced Medicinal Products Authorized in the European Union and in the United States of America Between 2009 and 2023

Documenti analoghi

• A Natural Language Processing Approach Towards Harmonized Communication of Uncertainties Identified During the European Medicine Authorization Process
  di: Stefan Verweij, et al.
  Pubblicazione: (2024)
• Author Index
  Pubblicazione: (2025)
• Editorial: UDCA Dosing in PBC—Between Guideline Adherence and Clinical Reality: Authors' Reply
  di: Ellen Werner, et al.
  Pubblicazione: (2026)
• Letter: Prospective Individualised Validation of the GES in Predicting Hepatocellular Carcinoma—A ‘Precision Medicine’ Study: Authors' Reply
  di: Gamal Shiha, et al.
  Pubblicazione: (2025)
• Letter: Should ulcerative colitis be monitored more or less invasively? Authors' reply
  di: Matthias Lenfant, et al.
  Pubblicazione: (2024)